Lariciresinol

• Description:

  Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  360.406

• Molecular Formula:

  C20H24O6

• Notes:

  Research use only, not for human use.

• Receptor:

  VEGFR

• CAS Number:

  27003-73-2